A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)

John Paul Diaz

A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Jan 1 2020
Event	Journal of Clinical Oncology - Duration: Jan 1 2020 → …

Conference

Conference	Journal of Clinical Oncology
Period	1/1/20 → …

Cite this

@conference{1badbf31d3b34e3b93d753cb21504e2c,

title = "A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)",

author = "Diaz, {John Paul}",

note = "Journal of Clinical Oncology (2020) 38(15 Supp):6016-6016; Journal of Clinical Oncology ; Conference date: 01-01-2020",

year = "2020",

month = jan,

day = "1",

language = "American English",

}

TY - CONF

T1 - A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)

AU - Diaz, John Paul

N1 - Journal of Clinical Oncology (2020) 38(15 Supp):6016-6016

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3881

M3 - Presentation

T2 - Journal of Clinical Oncology

Y2 - 1 January 2020

ER -

A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)

Conference

Other files and links

Cite this